Clinical Research Directory
Browse clinical research sites, groups, and studies.
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
Sponsor: University of Mississippi Medical Center
Summary
The purpose of this study is to learn if giving 17-hydroxyprogesterone caproate (17 OHPC) to mothers with preeclampsia diagnosed before 34 weeks gestation improves mother and baby outcomes.
Official title: Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2017-05-22
Completion Date
2027-01-31
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
17 OHPC
The study participant will be given 17 OHPC, 250mg IM at admission and every 7 days thereafter.
Locations (1)
Winfred L. Wiser Hospital
Jackson, Mississippi, United States